Stocks
Denali Therapeutics (DNLI) P/BV US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | 5.63 | 3.35 | 2.86 | 2.73 | 2.86 | 4.11 | ||
| Changes by years, y/y, % | -29% | -41% | -15% | -5% | +5% | -18.5% | |||
Denali Therapeutics. P/BV
Denali Therapeutics. P/BV, changes, %
Denali Therapeutics (DNLI) P/BV US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/BV | ? | 2.07 | 2.34 | 2.70 | 2.86 | 4.03 | 4.11 | |
| Changes by years, y/y, % | -2% | -17% | -28% | +1% | +94% | |||
| Changes by quarters, q/q, % | -26% | +13% | +16% | +6% | +41% | |||
